Combines a bim_population(), bim_market_share(), and bim_costs()
object into a complete budget impact model and computes the annual and
cumulative budget impact across all scenarios.
The budget impact for year t is defined as:
$$BI_t = \sum_i N_t \cdot s_i^{new}(t) \cdot c_i(t) - \sum_i N_t \cdot s_i^{current}(t) \cdot c_i(t)$$
where \(N_t\) is the number of eligible patients, \(s_i(t)\) is the market share of treatment \(i\), and \(c_i(t)\) is the cost per patient for treatment \(i\).
Usage
bim_model(
population,
market_share,
costs,
payer = bim_payer_default(),
discount_rate = 0,
label = NULL
)Arguments
- population
A
bim_populationobject frombim_population().A
bim_market_shareobject frombim_market_share().- costs
A
bim_costsobject frombim_costs().- payer
A
bim_payerobject frombim_payer()or one of the pre-built payer functions. Default isbim_payer_default().- discount_rate
numeric(1). Annual discount rate applied to Year 2+ costs. Per ISPOR guidelines, the base case should be undiscounted (0). Default0.- label
character(1)orNULL. Optional model label for reporting.
Value
An object of class bim_model, a list containing:
populationThe input
bim_populationobject.market_shareThe input
bim_market_shareobject.costsThe input
bim_costsobject.payerThe input
bim_payerobject.resultsA list with
annualandcumulativedata frames.metaA list with model metadata.
Examples
pop <- bim_population(
indication = "Disease X",
country = "GB",
years = 1:3,
prevalence = 0.003,
n_total_pop = 42e6,
eligible_rate = 0.30
)
ms <- bim_market_share(
population = pop,
treatments = c("RASi", "Sparsentan", "Sibeprenlimab"),
new_drug = "Sibeprenlimab",
shares_current = c(RASi = 0.75, Sparsentan = 0.25, Sibeprenlimab = 0.00),
shares_new = c(RASi = 0.60, Sparsentan = 0.20, Sibeprenlimab = 0.20)
)
costs <- bim_costs(
treatments = c("RASi", "Sparsentan", "Sibeprenlimab"),
drug_costs = c(RASi = 200, Sparsentan = 22000, Sibeprenlimab = 28500)
)
model <- bim_model(pop, ms, costs, label = "IgAN BIM")
summary(model)
#>
#> == htaBIM Model Summary ==
#> =======================================================
#> Label : IgAN BIM
#> Indication : Disease X
#> Country : GB
#> Currency : GBP (2026 prices)
#> New drug : Sibeprenlimab
#> Payer : Healthcare system (default)
#> Discount : 0.0%
#> -------------------------------------------------------
#> Scenario: BASE
#> Year Budget (curr) Budget (new) Impact
#> 1 GBP 213,570,000 GBP 386,316,000 GBP 172,746,000
#> 2 GBP 213,570,000 GBP 386,316,000 GBP 172,746,000
#> 3 GBP 213,570,000 GBP 386,316,000 GBP 172,746,000
#>
#> Cumulative impact (3 yrs): GBP 518,238,000
#>